Recommendations for Syndromic Surveillance Using Inpatient and Ambulatory EHR Data

MUse will make EHR data increasingly available for public health surveillance. For Stage 2, the Centers for Medicare & Medicaid Services (CMS) regulations will require hospitals and offer an option for eligible professionals to provide electronic syndromic surveillance data to public health. Together, these data can strengthen public health surveillance capabilities and population health outcomes (Figure 1). To facilitate the adoption and effective use of these data to advance population health, public health priorities and system capabilities must shape standards for data exchange.

July 05, 2018

2012 ISDS Recommendations for the Syndromic Surveillance Frontier Inpatient and Ambulatory Clinical Data Sources

Advances in health information technology are providing exciting opportunities to expand public health surveillance capabilities with the addition of more timely electronic health data. Additionally, the implementation of the Meaningful Use provisions of the HITECH Act presents public health agencies (PHAs) with a chance to develop systems that enhance public health monitoring, prevention, and response activities through the use of novel data sources.

October 16, 2017

Linking Informatics and Cross-Programmatic Public Health Strategic Objectives

There is national recognition of the need for cross-programmatic data and system coordination and integration for surveillance, prevention, response, and control implementation. To accomplish this public health must develop an informatics competency and create an achievable roadmap, supported by performance measures, for the future.

May 02, 2019

The utility of inpatient data obtained from regional health information organizations for pneumonia and influenza surveillance

Hospital discharge data received by public health agencies has a reporting lag time of greater than six months. This data is often used retrospectively to conduct surveillance to assess severity of illness and outcome, and for evaluating performance of public health surveillance systems. 

June 20, 2019

Medicaid Prescription Data for Detection of Influenza-Like Illness

The New York State (NYS) Medicaid Program provides healthcare for 34% of the population in New York City (NYC) and 4%-20% in each of the 57 county populations up-state. Prescription data are collected through the sub-mission of claims forms to the Medicaid Program and transmitted daily to the NYS Syndromic Surveillance Program as summary counts by drug category and patient’s ZIP Code, age category, and sex. One of the 18 drug categories is influenza agents, which in-cludes rimantadine, oseltamivir, and zanamivir.

March 26, 2019

Contact Us

NSSP Community of Practice



This website is supported by Cooperative Agreement # 6NU38OT000297-02-01 Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health between the Centers for Disease Control and Prevention (CDC) and the Council of State and Territorial Epidemiologists. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. CDC is not responsible for Section 508 compliance (accessibility) on private websites.

Site created by Fusani Applications